Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-08

Clinical Trial Update: Effects of Spironolactone on Collagen Metabolism in Patients With Pulmonary Arterial Hypertension [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining the effects of spironolactone on collagen metabolism in patients with pulmonary arterial hypertension. Sponsored by Bayl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spironolactone (spironolactone)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Pulmonary Hypertension | Phase 4 | Status: UNKNOWN